全长LGR4-RSPOs复合体的冷EM结构和针对性纳米体用于抗肥胖治疗

Zhongyun Zhang1,2, Lu Wang3, Huarui Qiao3,4,5

  • 1Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Nature communications
|September 25, 2025
PubMed
概括

研究人员确定了氨酸丰富的重复含有G蛋白结合受体4 (LGR4) 作为肥胖的目标. 一种抑制性纳米体 (NB21) 阻断LGR4,促进脂肪色和减肥.